Investor Atlas

2080 Ventures · Investor research

49 investors focused on Cannabis targeting France

Compare 49 investors focused on Cannabis targeting France. Review the selection, investor types and reported focus with 2080 Ventures.

49matching investors
6individual investors
43organizations

What this selection covers

This guide contains 49 distinct directory identities matching target markets: France; sectors: Cannabis. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting France” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Investor types represented: Venture Capital (31), Angel Investor (6), Accelerator (5), Angel Network (3).

Prepare a focused approach

For Cannabis, compare the investor’s thesis and recent portfolio with your customer, business model and technical needs. A broad sector tag alone does not establish fit.

Before pitching for France, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

  1. Check the current mandate and recent investments.
  2. Confirm check size, lead or follow preference, and company eligibility.
  3. Identify the relevant partner and published pitch route.
  4. Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 49 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

InvestorInvestor typeResearch
Abingworth
Venture CapitalView profile ↗
Ace of Cups
Angel NetworkView profile ↗
Advanced Technology Ventures
Venture CapitalView profile ↗
Amy Chen
Angel InvestorView profile ↗
Anaxago
Venture CapitalView profile ↗
Ardian
Private EquityView profile ↗
Asabys Partners
Venture CapitalView profile ↗
Berkeley SkyDeck
AcceleratorView profile ↗
Beta Lab
Venture CapitalView profile ↗
Bioqube Ventures
Venture CapitalView profile ↗
Boehringer Ingelheim Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
Elisabeth Zambelis
Angel InvestorView profile ↗
EXPERT DOJO
Venture Capital, AcceleratorView profile ↗
FDJ Ventures
Corporate Venture CapitalView profile ↗
Fiddlehead Ventures
Venture CapitalView profile ↗
Flashpoint VC
Venture CapitalView profile ↗
General Inception
Startup StudioView profile ↗
Genoa Ventures
Venture CapitalView profile ↗
Great Eagle Holdings
Corporate Venture CapitalView profile ↗
Hedi Ben Chaabane
Angel InvestorView profile ↗
Henry Stebbins
Angel InvestorView profile ↗
i&i Prague
AcceleratorView profile ↗
IndieBio
Venture CapitalView profile ↗
Leafy Tunnel
Venture CapitalView profile ↗
Lightstone Ventures
Venture CapitalView profile ↗
Lope Calvo de Quinto
Angel InvestorView profile ↗
Marwari Catalysts
Angel Network, Accelerator, Venture Capital, Family OfficeView profile ↗
Medin VC
Venture CapitalView profile ↗
Mer Angels
Angel NetworkView profile ↗
Metaplanet
Venture CapitalView profile ↗
Michael Wieser
Angel InvestorView profile ↗
Mindshift Ventures
Venture CapitalView profile ↗
NEFES Holding
Venture CapitalView profile ↗
OrbiMed
Private EquityView profile ↗
Pace Ventures
Venture CapitalView profile ↗
Panakes Partners
Venture CapitalView profile ↗
Polaris Partners
Venture CapitalView profile ↗
Pureos Bioventures
Venture CapitalView profile ↗
SEE UP Accelerator
AcceleratorView profile ↗
Seven Capital
Venture CapitalView profile ↗
Seventure - Life Sciences
Venture CapitalView profile ↗
Sherpa Venture Capital
Venture CapitalView profile ↗
Sofinnova Partners
Venture CapitalView profile ↗
The Moon Venture
Venture CapitalView profile ↗
Vsquared Ventures
Venture CapitalView profile ↗
Wellcome Trust
Public FundView profile ↗
Xerys
Private EquityView profile ↗
Yaya Capital
Venture CapitalView profile ↗
ZAKA VC
Venture CapitalView profile ↗

How these guides are compiled. Source-reported criteria may change. A listing does not confirm current investment activity.